Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Development of Novel Physiological CMR Methods in Health and Disease

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Der Link wird in der Zwischenablage gespeichert
StatusRekrutierung
Sponsoren
Sheffield Teaching Hospitals NHS Foundation Trust

Schlüsselwörter

Abstrakt

Physiological cardiovascular stress test plays a crucial role in the assessment of patients with suspected heart disease. There are several methods of cardiac physiological stress tests and each of them offer varied insight into cardiac physiological adaptation: passive leg raise, intra-venous fluid challenge, pharmacological stressors and physical exercise stress test. Echocardiography, which is the mainstay for the non-invasive rest/stress assessment of the left ventricular (LV) haemodynamics has several limitations. Novel methods of CMR imaging allow to map intra-cardiac flow in three-dimension using novel flow acquisitions. These novel flow acquisitions are called four-dimensional flow CMR, where the fourth dimension is time. Additionally, traditional cine CMR imaging for functional assessment can now be done without breath-holds using advanced acceleration methods, allowing them to be used during exercise. A comprehensive understanding of functional-flow coupling at rest, during increased pre-load (fluid challenge) to the heart or during exercise, is lacking in the literature. There is an important need to validate these novel CMR methods for developing mechanistic insight into physiological cardiac adaptation to increased pre-load or to exercise in health and how it alters in heart disease.

Beschreibung

For this study, the investigators will perform comprehensive physiological CMR in healthy volunteers and patients with suspected or known heart disease (coronary artery disease and heart failure). A sub-set of patients will have follow-up scans after they receive treatment to investigate the therapeutic target role of these physiological CMR metrics.

Patients who have given informed consent for this research will receive one physiological stress test depending on the clinical context. There will be 5 clinical subgroups to which patients will be recruited to:

Group 1. Heart failure with preserved ejection fraction (HFpEF), Group 2. Heart failure with reserved ejection fraction (HFrEF), Group 3. Pulmonary hypertension (PH), Group 4. Acute myocardial infarction (AMI) and Group 5. Suspected but not treated coronary artery disease (sCAD).

Patients will be selected in each group by the clinical specialist/research team as per the published guidelines and local protocols - Group 1 and 2 (19), Group 3 (20), Group 4 (21) and Group 5 (22).

First 4 groups of patients will receive pre-load increasing stress test (either passive leg raise or equivalent 500mls intravenous fluid challenge depending on the tolerability). This will be done to investigate if increase in pre-load will help unravel subtle dysfunction which is not apparent at euvolemic state. AMI patients may also receive ischaemia testing stress CMR depending on the main clinically question needed to answer. Patients with sCAD will receive clinically relevant pharmacological stress test (dobutamine, adenosine or regadenoson, inhaled nitric oxide) to diagnose ischaemia.

Healthy volunteers who have given informed consent will receive matched physiological stress test so that head-on comparison can be made with the relevant patient cohort. The CMR scan protocol will involve minimal breath-holds and will be patient-friendly. This is achieved by using accelerated, advanced cine and late gadolinium enhancement (LGE)-imaging techniques which require fewer breath-holds and shorter scan. All CMR stress studies will be supervised by an Advanced Life Support (ALS) certified doctor.

The CMR protocol for healthy volunteers will include the following components (45 minutes):

1. Survey

2. Baseline cine imaging for functional imaging (rest)

3. Tissue characterisation with native T1-mapping (rest)

4. 4D flow CMR (rest)

5. Record blood pressure, heart rate and oxygen saturation

6. Start of physiological stress (increase pre-load or pharmacological stressors)

7. 4D flow CMR (stress, at low-moderate intensity exercise aiming for heart rate up to 110bpm only)

8. Functional cines (stress, at low-moderate intensity exercise aiming for heart rate up to 110bpm only)

9. Record blood pressure, heart rate and oxygen saturation

10. First pass perfusion imaging (only if adenosine/regadenoson used for myocardial hyperaemia)

11. Record blood pressure, heart rate and oxygen saturation

12. Gadolinium contrast injection

13. Early/Late gadolinium enhancement imaging in short-axis

14. Post contrast T1-mapping End of study

For patient's receiving clinical CMR scans, the 'bolt-on' stress CMR protocol will include the following components (20-25minutes):

1. 4D flow CMR (rest)

2. Record blood pressure, heart rate and oxygen saturation

3. Start of physiological stress (increase pre-load or pharmacological stressors)

4. 4D flow CMR (stress, at low-moderate intensity exercise aiming for heart rate up to 110bpm only)

5. Functional cines (stress, at low-moderate intensity exercise aiming for heart rate up to 110bpm only)

6. Record blood pressure, heart rate and oxygen saturation

7. First pass perfusion imaging (only if adenosine/regadenoson used for myocardial hyperaemia)

8. Record blood pressure, heart rate and oxygen saturation

Termine

Zuletzt überprüft: 02/29/2020
Zuerst eingereicht: 02/18/2019
Geschätzte Einschreibung eingereicht: 02/24/2019
Zuerst veröffentlicht: 02/25/2019
Letztes eingereichtes Update: 03/16/2020
Letztes Update veröffentlicht: 03/17/2020
Tatsächliches Startdatum der Studie: 07/29/2018
Geschätztes primäres Abschlussdatum: 06/03/2022
Voraussichtliches Abschlussdatum der Studie: 06/04/2023

Zustand oder Krankheit

Heart Failure
Pulmonary Hypertension
Myocardial Infarction
Coronary Artery Disease

Intervention / Behandlung

Other: intravenous fluid challenge

Phase

-

Armgruppen

ArmIntervention / Behandlung
Other: Group 1
Heart failure patients with preserved ejection fraction
Other: Group 2
Heart failure patients with reserved ejection fraction
Other: Group 3
Patients with pulmonary hypertension
Other: Group 4
Patients with acute myocardial infarction
Other: Group 5
Patients with suspected but not treated coronary artery disease
Other: Group 6
Healthy Volunteers

Zulassungskriterien

Altersberechtigt für das Studium 20 Years Zu 20 Years
Studienberechtigte GeschlechterAll
Akzeptiert gesunde FreiwilligeJa
Kriterien

Inclusion Criteria:

- Healthy Volunteers age 20 to 80, recruited from Sheffield Teaching Hospitals staff members

- Patients age 20 to 80 with suspected or known heart disease (group 1 to 5)

- Capable of giving written informed consent

Exclusion Criteria:

- Inability to perform the study protocol secondary to severe heart failure requiring IV therapy

- Patients recruited in the suspected CAD and acute myocardial infarction arms of the study and in need for detection of ischaemia should not have any past medical history of MI, ACS or cardiomyopathy

- Patients with significant valvular heart disease will be excluded from any patient group

- Patient with in atrial fibrillation will be excluded

- Contraindication to MRI (as per standard MRI screening questionnaire issued to patients prior to clinical MRI procedures)

Ergebnis

Primäre Ergebnismaße

1. 4D CMR Flow [Through study completion, average 5 years]

The primary outcome measures will include 4D flow CMR derived mitral inflow diastolic parameter: E/A ratio. This parameter will be quantified once both at rest and during physiological stress.

Sekundäre Ergebnismaße

1. Secondary 4D CMR Flow [Through study completion, average 5 years]

Other 4D flow CMR derived outcome metrics will include mitral, tricuspid and pulmonary valve flow quantification - net forward flow (mls), E-velocity (cm/sec), E-velocity deceleration time (msec, both for mitral and tricuspid), A-velocity (cm/sec) and valvular regurgitation (mls).

2. Volumetric and functional parameters [Through study completion, average 5 years]

2) Right and left heart volumetric and functional parameters: end-diastolic and end-systolic volumes; ejection fraction

Treten Sie unserer
Facebook-Seite bei

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird

  • Arbeitet in 55 Sprachen
  • Von der Wissenschaft unterstützte Kräuterkuren
  • Kräutererkennung durch Bild
  • Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
  • Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
  • Suchen Sie nach Heilkräutern nach ihrer Wirkung
  • Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden

Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen

Google Play badgeApp Store badge